These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22553452)

  • 1. Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats.
    Jullien M; Thériault G; Bergeron MG; Beauchamp D
    Can J Infect Dis; 1990; 1(4):117-20. PubMed ID: 22553452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of E. coli pyelonephritis on the intracortical accumulation kinetics of gentamicin and netilmicin in rats.
    Beauchamp D; Bouchard A; Thériault G; Pellerin M; Bergeron MG
    Clin Invest Med; 1990 Aug; 13(4):145-51. PubMed ID: 2208829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on the intracortical accumulation kinetics of gentamicin in rats.
    Beauchamp D; Gourde P; Bergeron MG
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2006-8. PubMed ID: 2610510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.
    Auclair P; Lessard C; Bergeron MG
    Antimicrob Agents Chemother; 1988 May; 32(5):736-9. PubMed ID: 3134849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats.
    Tardif D; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 1990 Apr; 34(4):576-80. PubMed ID: 2344164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cortical uptake kinetics of gentamicin in rats with impaired renal function.
    Verpooten GA; Giuliano RA; Pattyn VM; Scharpé SL; De Broe ME
    Am J Kidney Dis; 1986 Nov; 8(5):304-7. PubMed ID: 3788969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.
    LeBrun M; Grenier L; Gourde P; Bergeron MG; Labrecque G; Beauchamp D
    Antimicrob Agents Chemother; 1999 May; 43(5):1020-6. PubMed ID: 10223909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.
    Bergeron MG; Trottier S; Lessard C; Beauchamp D; Gagnon PM
    J Infect Dis; 1982 Sep; 146(3):436-9. PubMed ID: 7050257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of intrarenal concentrations of gentamicin for the outcome of experimental pyelonephritis in rats.
    Bergeron MG; Bastille A; Lessard C; Gagnon PM
    J Infect Dis; 1982 Jul; 146(1):91-6. PubMed ID: 7045256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
    Miniter PM; Patterson TF; Johnson MA; Andriole VT
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1199-203. PubMed ID: 2820299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
    Furustrand Tafin U; Majic I; Zalila Belkhodja C; Betrisey B; Corvec S; Zimmerli W; Trampuz A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4821-7. PubMed ID: 21807979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of pyelonephritis due to Escherichia coli in rats with gentamicin stored in kidney tissue.
    Glauser MP; Lyons JM; Braude AI
    J Infect Dis; 1979 Feb; 139(2):172-7. PubMed ID: 374643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice.
    Tsuchimori N; Hayashi R; Shino A; Yamazaki T; Okonogi K
    Infect Immun; 1994 Oct; 62(10):4534-41. PubMed ID: 7927719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.
    Giuliano RA; Verpooten GA; Verbist L; Wedeen RP; De Broe ME
    J Pharmacol Exp Ther; 1986 Feb; 236(2):470-5. PubMed ID: 3944768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis.
    Wells VD; Wong ES; Murray BE; Coudron PE; Williams DS; Markowitz SM
    Ann Intern Med; 1992 Feb; 116(4):285-92. PubMed ID: 1733382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats.
    Giuliano RA; Verpooten GA; De Broe ME
    Am J Kidney Dis; 1986 Nov; 8(5):297-303. PubMed ID: 3788968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.
    Aslangul E; Massias L; Meulemans A; Chau F; Andremont A; Courvalin P; Fantin B; Ruimy R
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3615-21. PubMed ID: 17065620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis.
    Bergeron MG; Marois Y
    Kidney Int; 1986 Oct; 30(4):481-7. PubMed ID: 3537452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.
    Ibrahim SL; Zhang L; Brady TM; Hsu AJ; Cosgrove SE; Tamma PD
    Clin Infect Dis; 2015 Oct; 61(7):1119-24. PubMed ID: 26082503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.